Funded Tech Companies
Wondering who provided funding to Calporta Therapeutics? Private investors and Avalon Ventures invested in this innovative biopharmaceutical company.
Private & Independent
Company Background Information
Calporta is developing selective small molecule agonists of TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1) for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases.
Browse more funded tech companies:
CaloSyn Pharma | CalStar Products
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs